Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 1
1992 2
1997 2
2002 3
2003 4
2004 2
2005 8
2006 7
2007 7
2008 2
2009 2
2010 5
2011 3
2012 3
2013 4
2014 4
2015 6
2016 3
2017 6
2018 5
2019 4
2020 6
2021 3
2022 4
2023 1
2024 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Severe Acute Liver Injury After Hepatotoxic Medication Initiation in Real-World Data.
Torgersen J, Mezochow AK, Newcomb CW, Carbonari DM, Hennessy S, Rentsch CT, Park LS, Tate JP, Bräu N, Bhattacharya D, Lim JK, Mezzacappa C, Njei B, Roy JA, Taddei TH, Justice AC, Lo Re V 3rd. Torgersen J, et al. Among authors: brau n. JAMA Intern Med. 2024 Aug 1;184(8):943-952. doi: 10.1001/jamainternmed.2024.1836. JAMA Intern Med. 2024. PMID: 38913369 Free PMC article.
Hepatocellular carcinoma in people living with HIV.
Fulgenzi CAM, Dalla Pria A, Leone AG, Celsa C, Cabibbo G, Scheiner B, Pinter M, D'Alessio A, Zhao Y, Brau N, Bower M, Pinato DJ. Fulgenzi CAM, et al. Among authors: brau n. J Hepatol. 2025 Oct;83(4):971-981. doi: 10.1016/j.jhep.2025.04.028. Epub 2025 Apr 30. J Hepatol. 2025. PMID: 40316049 Free article. Review.
Hepatotoxicity Score: A New Method to Adjust for Use of Potentially Hepatotoxic Medications by Chronic Liver Disease Status.
Lo Re V 3rd, Newcomb CW, Carbonari DM, Mezochow AK, Hennessy S, Rentsch CT, Park LS, Tate JP, Bräu N, Bhattacharya D, Lim JK, Mezzacappa C, Njei B, Roy JA, Taddei TH, Justice AC, Torgersen J. Lo Re V 3rd, et al. Among authors: brau n. Pharmacoepidemiol Drug Saf. 2024 Dec;33(12):e70069. doi: 10.1002/pds.70069. Pharmacoepidemiol Drug Saf. 2024. PMID: 39662972 Free PMC article.
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.
Rosas IO, Bräu N, Waters M, Go RC, Hunter BD, Bhagani S, Skiest D, Aziz MS, Cooper N, Douglas IS, Savic S, Youngstein T, Del Sorbo L, Cubillo Gracian A, De La Zerda DJ, Ustianowski A, Bao M, Dimonaco S, Graham E, Matharu B, Spotswood H, Tsai L, Malhotra A. Rosas IO, et al. Among authors: brau n. N Engl J Med. 2021 Apr 22;384(16):1503-1516. doi: 10.1056/NEJMoa2028700. Epub 2021 Feb 25. N Engl J Med. 2021. PMID: 33631066 Free PMC article. Clinical Trial.
Impact of High-Titer Convalescent Plasma on Clinical and Virologic Outcomes Among Veterans Hospitalized With SARS-CoV-2 Infection: VA CoronavirUs Research and Efficacy Studies-1 (VA CURES-1).
Janoff EN, Shih MC, Donskey C, Belitskaya-Levy I, Brau N, Rodriguez-Barradas MC, Chan E, Zimmerman P, Miller EK, Vaughan LB, Daniel Markley J, Goldberg AM, Sriram P, Anzueto A, Uyeda L, Zehm L, Wills A, Hutchinson C, Jones L, Peterson D, Ringer RJ, Dumont L, Gleason T, Bonomo RA, Curtis JL, Brown ST; CURES‐1 Trials Consortium. Janoff EN, et al. Among authors: brau n. J Med Virol. 2025 May;97(5):e70349. doi: 10.1002/jmv.70349. J Med Virol. 2025. PMID: 40400480 Clinical Trial.
A Learning Health System Approach to Long COVID Care.
Gustavson AM, Purnell A, Adly M, Awan O, Bräu N, Braus NA, Bryant MS, Chang L, Cyborski C, Darvish B, Del Piero LB, Eaton TL, Kiliveros A, Kloth H, McNiel ER, Miller MA, Patrick A, Powers P, Pyne M, Rodriguez IG, Romesser J, Rud B, Seidel I, Tepper A, Trinh H, Tonkin B, Vachachira J, Yang H, Shak JR. Gustavson AM, et al. Among authors: brau n. Fed Pract. 2022 Jul;39(7):310-314. doi: 10.12788/fp.0288. Epub 2022 Jul 11. Fed Pract. 2022. PMID: 36425345 Free PMC article.
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.
Afdhal N, Zeuzem S, Kwo P, Chojkier M, Gitlin N, Puoti M, Romero-Gomez M, Zarski JP, Agarwal K, Buggisch P, Foster GR, Bräu N, Buti M, Jacobson IM, Subramanian GM, Ding X, Mo H, Yang JC, Pang PS, Symonds WT, McHutchison JG, Muir AJ, Mangia A, Marcellin P; ION-1 Investigators. Afdhal N, et al. Among authors: brau n. N Engl J Med. 2014 May 15;370(20):1889-98. doi: 10.1056/NEJMoa1402454. Epub 2014 Apr 11. N Engl J Med. 2014. PMID: 24725239 Free article. Clinical Trial.
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.
Naggie S, Cooper C, Saag M, Workowski K, Ruane P, Towner WJ, Marks K, Luetkemeyer A, Baden RP, Sax PE, Gane E, Santana-Bagur J, Stamm LM, Yang JC, German P, Dvory-Sobol H, Ni L, Pang PS, McHutchison JG, Stedman CA, Morales-Ramirez JO, Bräu N, Jayaweera D, Colson AE, Tebas P, Wong DK, Dieterich D, Sulkowski M; ION-4 Investigators. Naggie S, et al. Among authors: brau n. N Engl J Med. 2015 Aug 20;373(8):705-13. doi: 10.1056/NEJMoa1501315. Epub 2015 Jul 21. N Engl J Med. 2015. PMID: 26196665 Free PMC article. Clinical Trial.
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection.
Foster GR, Afdhal N, Roberts SK, Bräu N, Gane EJ, Pianko S, Lawitz E, Thompson A, Shiffman ML, Cooper C, Towner WJ, Conway B, Ruane P, Bourlière M, Asselah T, Berg T, Zeuzem S, Rosenberg W, Agarwal K, Stedman CA, Mo H, Dvory-Sobol H, Han L, Wang J, McNally J, Osinusi A, Brainard DM, McHutchison JG, Mazzotta F, Tran TT, Gordon SC, Patel K, Reau N, Mangia A, Sulkowski M; ASTRAL-2 Investigators; ASTRAL-3 Investigators. Foster GR, et al. Among authors: brau n. N Engl J Med. 2015 Dec 31;373(27):2608-17. doi: 10.1056/NEJMoa1512612. Epub 2015 Nov 17. N Engl J Med. 2015. PMID: 26575258 Free article. Clinical Trial.
90 results